HDFC Securities has issued a buy recommendation for Medplus Health Services, setting a target price of Rs 820 per share. Currently, the market price of Medplus Health Services Ltd. stands at Rs 667.9.
Company Overview:
Medplus Health Services Ltd., established in 2006, operates in the retail sector and is classified as a Large Cap company with a market capitalization of Rs 7,993.44 crore. The company’s primary revenue segments include pharmaceuticals, sale of services, and other operating revenues.
Financial Performance:
For the quarter ending March 31, 2024, Medplus Health Services reported a consolidated total income of Rs 1,500.96 crore. This represents a 3.42% increase from the previous quarter and an 18.50% rise from the same quarter last year. The company achieved a net profit after tax of Rs 33.56 crore in the latest quarter.
Promoter and Investor Holdings:
As of March 31, 2024, promoters hold a 40.39% stake in Medplus Health Services, while Foreign Institutional Investors (FIIs) own 14.94% and Domestic Institutional Investors (DIIs) hold 22.47%.
Outlook:
HDFC Securities remains bullish on Medplus Health Services, expecting significant potential with a target price of Rs 820 per share.
Disclaimer: The views and investment tips expressed by investment experts on Sharepriceindia.com are their own and not those of the website or its management. Sharepriceindia.com advises users to check with certified experts before taking any investment decisions.
